Testing effectiveness (Phase 2)Looking for participantsNCT06138990What this trial is testingPharmacoscopy-guided Clinical Standard-of-care in r/r AMLWho this might be right forAML, Adult ETH Zurich 88
Testing effectiveness (Phase 2)Study completedNCT01883362What this trial is testingStandard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AMLWho this might be right forAcute Myeloid Leukemia Novartis Pharmaceuticals 60
Very early researchUnknownNCT03795779What this trial is testingCLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesWho this might be right forHematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more iCell Gene Therapeutics 20
Early research (Phase 1)UnknownNCT04796688What this trial is testingUniversal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphoblastic LeukemiaB-cell Lymphoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Testing effectiveness (Phase 2)Looking for participantsNCT05334823What this trial is testingPCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and AdolescentsWho this might be right forAcute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia Chongqing Precision Biotech Co., Ltd 100
Testing effectiveness (Phase 2)Looking for participantsNCT07070323What this trial is testingA Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte MalignanciesWho this might be right forT-Cell Acute Lymphocytic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia+1 more Beijing GoBroad Hospital 54
Early research (Phase 1)Ended earlyNCT02676323What this trial is testingPanobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome St. Jude Children's Research Hospital 19
Early research (Phase 1)Study completedNCT00004862What this trial is testingAugmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00087204What this trial is testingRebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+13 more National Cancer Institute (NCI) 40
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06532084What this trial is testingSorafenib Relapase Prophylaxis After HCT With PTBCy RegimenWho this might be right forAcute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more St. Petersburg State Pavlov Medical University 88
Early research (Phase 1)Looking for participantsNCT06690827What this trial is testingClinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCNWho this might be right forAML (Acute Myeloid Leukemia)BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT05115630What this trial is testingOff-the-shelf NK Cells + SCT for Myeloid MalignanciesWho this might be right forMyeloid MalignanciesAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)WithdrawnNCT06351306What this trial is testingDEC-C and Thioguanine for R/R AMLWho this might be right forAcute Myeloid Leukemia Columbia University
Testing effectiveness (Phase 2)UnknownNCT00002532What this trial is testingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaWho this might be right forLeukemia Hannover Medical School
Large-scale testing (Phase 3)Study completedNCT00005863What this trial is testingCombination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Medical Research Council
Early research (Phase 1)Study completedNCT01523977What this trial is testingEverolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLWho this might be right forAcute Lymphoblastic Leukemia Dana-Farber Cancer Institute 22
Early research (Phase 1)Study completedNCT00002912What this trial is testingCombination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 3
Early research (Phase 1)Ended earlyNCT05038800What this trial is testingEvaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)Who this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Chronic Myelomonocytic Leukemia Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)Study completedNCT02395822What this trial is testingMT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML PatientsWho this might be right forAcute Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 17